UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 175

Sortiert nach

In vitro and in vivo models of non-alcoholic fatty liver disease (NAFLD)

International Journal of Molecular Sciences, 2013-06, Vol.14 (6), p.11963-11980

2013

Link zum Volltext

Verfügbarkeit prüfen

The Intestinal Barrier Dysfunction as Driving Factor of Inflammaging

Nutrients, 2022-02, Vol.14 (5), p.949

2022

Link zum Volltext

Verfügbarkeit prüfen

Markers of intestinal permeability are already altered in early stages of non-alcoholic fatty liver disease: Studies in children

PloS one, 2017-09, Vol.12 (9), p.e0183282-e0183282

2017

Link zum Volltext

Verfügbarkeit prüfen

Supplementation of sodium butyrate protects mice from the development of non-alcoholic steatohepatitis (NASH)

British journal of nutrition, 2015-12, Vol.114 (11), p.1745-1755

2015

Link zum Volltext

Verfügbarkeit prüfen

Sarcopenia and Liver Cirrhosis-Comparison of the European Working Group on Sarcopenia Criteria 2010 and 2019

Nutrients, 2020-02, Vol.12 (2), p.547

2020

Link zum Volltext

Verfügbarkeit prüfen

Kommentar zu „Zusammenhang zwischen Fruktosekonsum und intrahepatischem Fett untersucht

Aktuelle Ernährungsmedizin, 2023-02, Vol.48 (1), p.10-11

Bergheim, Ina

2023

Link zum Volltext

Verfügbarkeit prüfen

Toll‐like receptor 4 is involved in the development of fructose‐induced hepatic steatosis in mice

Hepatology (Baltimore, Md.), 2009-10, Vol.50 (4), p.1094-1104

2009

Link zum Volltext

Verfügbarkeit prüfen

Non-Alcoholic Fatty Liver Disease in Overweight Children: Role of Fructose Intake and Dietary Pattern

Nutrients, 2018-09, Vol.10 (9), p.1329

2018

Link zum Volltext

Verfügbarkeit prüfen

Lactobacillus rhamnosus GG protects against non-alcoholic fatty liver disease in mice

PloS one, 2014-01, Vol.9 (1), p.e80169

2014

Link zum Volltext

Verfügbarkeit prüfen

Metformin attenuates the onset of non-alcoholic fatty liver disease and affects intestinal microbiota and barrier in small intestine

Scientific reports, 2019-04, Vol.9 (1), p.6668, Article 6668

2019

Link zum Volltext

Verfügbarkeit prüfen

Metformin protects against the development of fructose-induced steatosis in mice: role of the intestinal barrier function

Laboratory investigation, 2012-07, Vol.92 (7), p.1020-1032

2012

Link zum Volltext

Verfügbarkeit prüfen

Diets rich in fructose, fat or fructose and fat alter intestinal barrier function and lead to the development of nonalcoholic fatty liver disease over time

The Journal of nutritional biochemistry, 2015-11, Vol.26 (11), p.1183-1192

2015

Link zum Volltext

Verfügbarkeit prüfen

Validation of Malnutrition Screening Tools in Liver Cirrhosis

Nutrients, 2020-05, Vol.12 (5), p.1306

2020

Link zum Volltext

Verfügbarkeit prüfen

Acute Intake of Sucrose but Not of the Intense Sweetener Sucralose Is Associated with Post-Prandial Endotoxemia in Healthy Young Adults—A Randomized Controlled Trial

Nutrients, 2023-09, Vol.15 (18), p.4038

2023

Link zum Volltext

Verfügbarkeit prüfen

Toll-like receptor 1 as a possible target in non-alcoholic fatty liver disease

Scientific reports, 2021-09, Vol.11 (1), p.17815-17815, Article 17815

2021

Link zum Volltext

Verfügbarkeit prüfen

A Xanthohumol-Rich Hop Extract Diminishes Endotoxin-Induced Activation of TLR4 Signaling in Human Peripheral Blood Mononuclear Cells: A Study in Healthy Women

International journal of molecular sciences, 2022-10, Vol.23 (20), p.12702

2022

Link zum Volltext

Verfügbarkeit prüfen

Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: Role of endotoxin

Journal of hepatology, 2008-06, Vol.48 (6), p.983-992

2008

Link zum Volltext

Verfügbarkeit prüfen

Markers of Intestinal Permeability Are Rapidly Improved by Alcohol Withdrawal in Patients with Alcohol-Related Liver Disease

Nutrients, 2021-05, Vol.13 (5), p.1659

2021

Link zum Volltext

Verfügbarkeit prüfen

GW9662, a peroxisome proliferator-activated receptor gamma antagonist, attenuates the development of non-alcoholic fatty liver disease

Metabolism, clinical and experimental, 2022-08, Vol.133, p.155233-155233, Article 155233

2022

Link zum Volltext

Verfügbarkeit prüfen

Adipokines and Endotoxemia Correlate with Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease (NAFLD)

Nutrients, 2020-03, Vol.12 (3), p.699

2020

Link zum Volltext

Verfügbarkeit prüfen

Preventive effects of citrulline on Western diet-induced non-alcoholic fatty liver disease in rats

British journal of nutrition, 2016-07, Vol.116 (2), p.191-203

2016

Link zum Volltext

Verfügbarkeit prüfen

Positive effect of an electrolyzed reduced water on gut permeability, fecal microbiota and liver in an animal model of Parkinson's disease

PloS one, 2019-10, Vol.14 (10), p.e0223238-e0223238

2019

Link zum Volltext

Verfügbarkeit prüfen

Loss of lipopolysaccharide-binding protein attenuates the development of diet-induced non-alcoholic fatty liver disease in mice

Journal of gastroenterology and hepatology, 2017-03, Vol.32 (3), p.708-715

2017

Link zum Volltext

Verfügbarkeit prüfen

Oral Supplementation of Sodium Butyrate Attenuates the Progression of Non-Alcoholic Steatohepatitis

Nutrients, 2020-03, Vol.12 (4), p.951

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 175

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(166)
Mit Volltextzugriff
(168)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Hepatology
(25)
Nutrients
(14)
The Journal Of Nutrition
(12)
European Journal Of Nutrition
(7)
The Journal Of Nutritional Biochemistry
(7)
Plos One
(6)
Redox Biology
(6)
Gastroenterology
(5)
Laboratory Investigation
(5)
Alcohol And Alcoholism
(4)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

In vitro and in vivo models of non-alcoholic fatty liver disease (NAFLD)

The Intestinal Barrier Dysfunction as Driving Factor of Inflammaging

Markers of intestinal permeability are already altered in early stages of non-alcoholic fatty liver disease: Studies in children

Supplementation of sodium butyrate protects mice from the development of non-alcoholic steatohepatitis (NASH)

Sarcopenia and Liver Cirrhosis-Comparison of the European Working Group on Sarcopenia Criteria 2010 and 2019

Kommentar zu „Zusammenhang zwischen Fruktosekonsum und intrahepatischem Fett untersucht

Toll‐like receptor 4 is involved in the development of fructose‐induced hepatic steatosis in mice

Non-Alcoholic Fatty Liver Disease in Overweight Children: Role of Fructose Intake and Dietary Pattern

Lactobacillus rhamnosus GG protects against non-alcoholic fatty liver disease in mice

Metformin attenuates the onset of non-alcoholic fatty liver disease and affects intestinal microbiota and barrier in small intestine

Metformin protects against the development of fructose-induced steatosis in mice: role of the intestinal barrier function

Intestinal dysbiosis augments liver disease progression via NLRP3 in a murine model of primary sclerosing cholangitis

Diets rich in fructose, fat or fructose and fat alter intestinal barrier function and lead to the development of nonalcoholic fatty liver disease over time

Validation of Malnutrition Screening Tools in Liver Cirrhosis

Acute Intake of Sucrose but Not of the Intense Sweetener Sucralose Is Associated with Post-Prandial Endotoxemia in Healthy Young Adults—A Randomized Controlled Trial

Toll-like receptor 1 as a possible target in non-alcoholic fatty liver disease

A Xanthohumol-Rich Hop Extract Diminishes Endotoxin-Induced Activation of TLR4 Signaling in Human Peripheral Blood Mononuclear Cells: A Study in Healthy Women

Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: Role of endotoxin

Markers of Intestinal Permeability Are Rapidly Improved by Alcohol Withdrawal in Patients with Alcohol-Related Liver Disease

GW9662, a peroxisome proliferator-activated receptor gamma antagonist, attenuates the development of non-alcoholic fatty liver disease

Adipokines and Endotoxemia Correlate with Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease (NAFLD)

Preventive effects of citrulline on Western diet-induced non-alcoholic fatty liver disease in rats

Positive effect of an electrolyzed reduced water on gut permeability, fecal microbiota and liver in an animal model of Parkinson's disease

Loss of lipopolysaccharide-binding protein attenuates the development of diet-induced non-alcoholic fatty liver disease in mice

Oral Supplementation of Sodium Butyrate Attenuates the Progression of Non-Alcoholic Steatohepatitis

Suchergebnisse filtern